(N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamate

monoamine oxidase B ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32250219 Exploring the Multifunctional Neuroprotective Promise of Rasagiline Derivatives for Multi-Dysfunctional Alzheimer's Disease. 2020 1
2 33375412 First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer's Disease. 2020 Dec 27 2
3 30108930 Design, synthesis and evaluation of indole derivatives as multifunctional agents against Alzheimer's disease. 2018 Feb 1 1
4 23410161 Rationally designed multi-targeted agents against neurodegenerative diseases. 2013 1
5 18751929 The novel cholinesterase-monoamine oxidase inhibitor and antioxidant, ladostigil, confers neuroprotection in neuroblastoma cells and aged rats. 2009 Feb 1
6 19110207 Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs. 2009 Jan 1
7 18598687 The neuroprotective effect of ladostigil against hydrogen peroxide-mediated cytotoxicity. 2008 Sep 25 2
8 16935943 A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing. 2006 Oct 1
9 17197368 Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil. 2006 Dec 3
10 15621213 Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. 2005 Feb 1
11 14697899 Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. 2004 Jan 1
12 15147504 Regulation of protein kinase C by the anti-Parkinson drug, MAO-B inhibitor, rasagiline and its derivatives, in vivo. 2004 Jun 2